LLY has been in the news 341% more than usual
Feb 25, 2026, 7:31 PM
-12.92%
What does LLY do
Eli Lilly & Co., headquartered in Indianapolis, employs 43,000 staff and develops various pharmaceutical products, including diabetes, oncology, immunology, and neuroscience therapies, alongside radiopharmaceuticals through its subsidiary POINT Biopharma. The company manufactures and distributes products in the U.S., Europe, and Asia.
LLY has been in the news recently: Eli Lilly's Zepbound demonstrated a 25% weight loss in trials, outperforming Novo Nordisk's CagriSema, which showed a 23% reduction. Following these results, Novo Nordisk's shares declined, indicating competitive pressures in the obesity treatment market.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.